Accès ouvert
2026
article
OpenAlex
Ivan Susin Pires, Ezra Gordon, Aidan Kindopp, Alexander D. Stoneman et autres
Engineering the surface chemistry of nanoparticles (NPs) via the electrostatic layer-by-layer (LbL) assembly approach is a viable strategy for developing targeted drug delivery vehicles. However, how assembly solution conditions and polymer molecular weight (MW) govern LbL-NP properties remains poorly understood. We investigated …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Victoria F. Gomerdinger, Cassandra Parada, An Li, Aidan Kindopp et autres
Innate immune agonists are promising therapeutic agents to induce immune responses against cancer. However, these agents have been limited by toxicity associated with systemic accumulation and activity in off-target cells. In this work, a targeted nanoparticle (NP) platform to encapsulate and protect …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Justin A. Kaskow, Altaf Bacchus, Victoria F. Gomerdinger, Adam G. Berger et autres
ABSTRACT Therapeutic activation of stimulator of interferon genes (STING) signaling shows promise as a method of inflaming the tumor microenvironment to generate an anti-cancer immune response. Frequent loss of STING expression in many human cancers renders small-molecule agonists ineffective in cancer cells. …
us
(code pays fourni par la source)
2026
dissertation
OpenAlex
Victoria F. Gomerdinger
Cancer is a devastating, complex disease driven by a multitude of biological and cellular factors. While there have been tremendous advancements in therapeutic strategies to target key vulnerabilities in cancer cells and the tumor microenvironment, the application of many promising agents has …
Accès ouvert
2026
preprint
OpenAlex
Justin A Kaskow, Julia Treese, Anita Gaenko, Victoria F. Gomerdinger et autres
Stimulator of interferon genes (STING) is a promising therapeutic target for cancer immunotherapy, but agonists are often rendered ineffective by the loss of STING expression in cancer cells. Here we engineer a multivalent peptide-polymer conjugate material that can easily be delivered to …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Elizabeth Bernice Nelson, Gil Covarrubias, Namita Nabar, Victoria F. Gomerdinger et autres
Nanoparticle drug delivery systems have significant potential to transform precision medicine due to their ability to encapsulate a wide range of cargo, improve systemic circulation time, and enhance targeted delivery. These delivery properties can be further modified by altering the surface chemistry …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ivan Susin Pires, Gil Covarrubias, Victoria F. Gomerdinger, Coralie M. Backlund et autres
Immunotherapies such as immune checkpoint inhibitors are effective in treating several advanced cancers, but these treatments have had limited success in metastatic ovarian cancer. Here we engineered liposomal nanoparticles carrying a poly-ʟ-arginine/poly-ʟ-glutamate coating that promotes their binding and retention on the surface …
us
(code pays fourni par la source)
2025
review
OpenAlex
Victoria F. Gomerdinger, Namita Nabar, Paula T. Hammond
us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Ivan Susin Pires, Gil Covarrubias, Victoria F. Gomerdinger, Coralie M. Backlund et autres
Immunotherapies such as checkpoint inhibitors (CPI) are effective in treating several advanced cancers, but these treatments have had limited success in metastatic ovarian cancer (OC). Here, we engineered liposomal nanoparticles (NPs) carrying a layer-by-layer (LbL) polymer coating that promotes their binding to …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Stephanie M. Kong, Pearl Moharil, Abram Handly‐Santana, Natalie Boehnke et autres
The majority of patients with high grade serous ovarian cancer (HGSOC) develop recurrent disease and chemotherapy resistance. To identify drug combinations that would be effective in treatment of chemotherapy resistant disease, we examined the efficacy of drug combinations that target the three …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Molly K. Grun, Alexandra Suberi, Kwangsoo Shin, Teresa Lee et autres
us
(code pays fourni par la source)